Attachment K -- Example of process and policy for no-blame policy for providers

Attachment K -- Example of process and policy for no-blame policy for providers.pdf

A PROTOTYPE CONSUMER REPORTING SYSTEM FOR PATIENT SAFETY EVENTS

Attachment K -- Example of process and policy for no-blame policy for providers

OMB: 0935-0214

Document [pdf]
Download: pdf | pdf
Tool 1 Attachments

12/2/02

4:10 PM

Page 1

Pathways

..............

for

.................

Medication Safety

sm

Leading a Strategic Planning Effort

Attachment 1.H

Policy for A Nonpunitive,
System-Based Adverse Drug Event
Reporting Program
Source: 2000 © Frederick Memorial Healthcare System, Frederick, MD. Reprinted with permission.

This attachment provides an example of a policy that details
a blame-free reporting program. Clear definitions, severity
classifications, and steps for staff to follow when reporting
an error are included as well as guidelines for trending the
information and using it to improve the medication
use systems.

www.medpathways.info

1.H.1

2002© American Hospital Association, Health Research & Educational Trust,
and the Institute for Safe Medication Practices

Tool 1 Attachments

12/2/02

4:10 PM

Page 2

Pathways

..............

for

.................

Medication Safety

sm

Leading a Strategic Planning Effort

Policy for A Non-Punitive, System-Based
Adverse Drug Event Reporting Program
Source: 2000 © Frederick Memorial Healthcare System, Frederick, MD. Reprinted with permission.

These guidelines are intended to assist in the delivery of patient care or management of hospital
services. They are not intended to replace professional judgment.

Policy Title
Adverse Drug Events
1.0 Purpose
To provide a standardized mechanism
for identifying, reporting, and monitoring
adverse drug events (ADEs) and to provide
a consistent mechanism for improving the
medication use process.
2.0 Scope
This policy applies to medication therapy for
all patients cared for in hospital departments,
main campus outpatient services, and
physician practices regardless of where the
medication was originally prescribed.
3.0 Definitions
Adverse Drug Event (ADE) - a deviation in
the medication use process (prescribing,
dispensing, administering, monitoring) or
undesirable clinical manifestation that is
consequent to and caused by the
administration or omission of medications, or
IV fluids as outlined in hospital policies and
procedures or within the scope of accepted
medical practice.
Significant ADE – An ADE categorized with
severity category 6 or 7 (see below). It should be
considered a sentinel event by hospital policy.

Adverse Drug Reaction (ADR) - is a subset
of ADEs that includes any clinical manifestation
that is undesired, unintended, or unexpected
that is consequent to and caused by the
administration of medications or IV fluids.
Preventable ADR - An ADR that resulted from
a deviation in the medication use process that
could be reasonably anticipated based upon
existing policies and procedures, patient data,
medical literature or accepted medical practice.
Medication Safety Improvement
Committee - a subcommittee of the Pharmacy
and Therapeutics (P&T) Committee that
reviews errors, trends, and significant ADEs
and makes recommendations for system-based
changes to improve the medication use process
(ie Fredrick Memorial’s “Saf-Med Committee”).
ADE Hotline - phone line to report
possible ADEs.
ADE Report Form - Form completed by any
member of hospital staff to document a
possible ADE.
ADE Review Form - Form used by ADE
Reviewers to assess and document to identify
causative factors in preparation for entry into
data base.

www.medpathways.info

1.H 2

2002© American Hospital Association, Health Research & Educational Trust,
and the Institute for Safe Medication Practices

Tool 1 Attachments

12/2/02

4:10 PM

Page 3

ADE Reviewer - Member of clinical staff
(pharmacist, nurse, radiology technologist,
respiratory therapist, physician) appointed
by the P&T Committee who reviews/assesses
reported ADEs, completes documentation,
and serves on the Medication Safety
Improvement Committee.

Pathways

..............

for

.................

Medication Safety

sm

Leading a Strategic Planning Effort

Clinical Interventions - Routines in the
Pharmacy computer system that allow
pharmacists to document interventions made to
clarify or optimize medication therapy, such as,
dosage adjustments, or nonformulary requests.

Category 4: An event occurred that
resulted in the need for treatment and/or
intervention and caused temporary
patient harm.
Category 5: An event occurred that resulted
in initial or prolonged hospitalization,
affected patient participation in an
investigational drug study, and/or caused
temporary patient harm.
Category 6: An event occurred that resulted
in permanent patient harm or near death
event, such as anaphylaxis.
Category 7: An event occurred that resulted
in patient death.

Severity:
Category 1: Circumstances or processes
that have the potential to cause an adverse
drug event.
Category 2: An event occurred but the
patient was not harmed.
Category 3: An event occurred that
resulted in the need for increased patient
assessments but no change in vital signs and
no patient harm.

www.medpathways.info

1.H.3

2002© American Hospital Association, Health Research & Educational Trust,
and the Institute for Safe Medication Practices

Tool 1 Attachments

12/2/02

4:10 PM

Page 4

Pathways

..............

for

.................

Medication Safety

sm

Leading a Strategic Planning Effort

4.0 Policy
4.1 Fredrick Memorial Healthcare System (FMH) encourages the reporting of adverse drug
events, and potential adverse drug events as a means to assess and improve the medication use
process and provide a safe environment for patient care. Thus, the focus of the program is
quality improvement, not punishment. FMH assumes that practitioners are doing their very
best and that errors and ADEs are not the result of gross negligence. Therefore, employees are
not subject to disciplinary action when making or reporting errors except in the following
circumstances:
●

●

●

The employee consistently fails to participate in the detection, reporting, and the systembased remedies to prevent errors.
There is reason to believe criminal activity or criminal intent may be involved in the
making or reporting of an ADE.
False information is provided in relation to the ADE report or investigation.

4.2 The reporting program is coordinated through the Pharmacy and Therapeutics Committee, as
part of the hospital’s performance improvement and peer review function, with participation
by Nursing and Pharmacy departments and the medical staff.
4.3 Pharmacists report ADRs to the FDA if they are serious, associated with a new drug, or not
mentioned in the drug’s labeling.
4.4 ADEs are reported by physicians, nurses, pharmacists, patients, medical records/QA personnel
or any member of the FMH staff. An ADE report form is completed or a call is made to the
ADE Hotline within 24 hours of the event’s identification.
4.5 Staff members identifying an ADE in severity category 6 or 7 above or classified as a sentinel
event reports the event, contacts the Administrator on call and follows the steps outlined in
the FMH Sentinel Event Policy and Procedure. A Root Cause Analysis is conducted in these
cases as outlined by standing FMH procedures.
5.0 Procedures and Responsibilities
5.1 Identifying an ADE
● Staff who receive a report of or suspect an ADE notify prescriber immediately if the event is
significant or may alter the patient’s plan of care.
● Staff assess the patient.
● Staff collaborate with clinical and supervisory resource personnel if unsure how to proceed.
● Staff implement adjustments in patient’s treatment as ordered.
● Staff document the factual description of the ADE, notification of physician and
subsequent monitoring in the progress record.

www.medpathways.info

1.H.4

2002© American Hospital Association, Health Research & Educational Trust,
and the Institute for Safe Medication Practices

Tool 1 Attachments

12/2/02

4:10 PM

Page 5

Pathways

..............

for

.................

Medication Safety

sm

Leading a Strategic Planning Effort

5.2 Reporting an ADE
● Staff calls the ADE hotline, completes the ADE reporting form or enters an ADE clinical
intervention in the Meditech Pharmacy-module within 24 hours of the ADE identification.
ADE forms are mailed, confidentially, to the Saf-Med Committee in the Pharmacy or put in
an ADE drop box. Pharmacy staff take ADE reports off Hotline seven days a week and
complete ADE Report forms.
● No copies are made of the ADE forms. Clinical interventions are migrated into a secure
database. Forms and data are secured in the Pharmacy and accessed by key or password.
5.3 Reviewing ADEs
●

●

●

●

Supervisor/manager completes timely evaluation of the circumstances surrounding
the event.
ADE Reviewers assess all reports, to verify and collect additional data, and assign severity
level. In the case of significant ADEs or medication-related sentinel events, reviewers
confirm notification of department director or manager, as well as compliance with
sentinel event policy. (see above 4.5).
ADE reports are reviewed using published criteria and categorized by: location, severity,
product information and therapeutic classification, type, causes and contributing factors.
ADR’s get an additional level of review. ADR’s are evaluated to determine:
1) appropriateness of medication for patient’s condition; 2) predisposing contraindications
to medication; 3) appropriate documentation of allergies; and 4) appropriate management
and monitoring of ADR.

5.4 Trending/Reporting/Improving the Medication Use Process
●

●

●

●

●

●

The Pharmacy Department performs the data entry, trending, and report distribution. The
Pharmacy prepares a quarterly analysis of ADE’s.
The Pharmacy forwards quarterly ADE trending reports to FMH managers. Managers are
responsible for analyzing their department data and responding with performance
improvement activities.
ADEs are tabulated monthly and reported to the Saf-Med Committee. Reports include ADE
and ADR rates.
The Saf-Med Committee reviews the monthly report, significant events, results of root
cause analysis and completion of consequent recommendations and makes
recommendations for improvements to the medication use process.
Saf-Med Committee reports and recommendations are made to the P&T Committee.
Minutes are distributed to the Safety Committee, P&T Committee Chair and Nursing
management. P&T Committee recommendations are forwarded to the medical staff
Quality Assurance Coordinating Committee.
Medication use improvements and recommendations are communicated to FMH staff via
e-mail, P&T minutes, Pharmacy Newsletter, educational offerings at medical staff and other
department meetings.

www.medpathways.info

1.H.5

2002© American Hospital Association, Health Research & Educational Trust,
and the Institute for Safe Medication Practices

Tool 1 Attachments

12/2/02

4:10 PM

Page 6

Pathways

..............

for

.................

Medication Safety

sm

Leading a Strategic Planning Effort

6.0 Documentation
Use ADE Report and Review forms.
7.0 Quality Assessment
ADE reports are trended monthly and reviewed at the Pharmacy and Therapeutics Committee
and Saf-Med Committee. The Committees make recommendations on surveillance, formulary
changes, educational efforts, and policy changes as necessary.
8.0 Exceptions
Adverse reactions that occur following the administration of investigational drugs are reported
according to the specific protocol for that drug by contacting the principle investigator. A
probationary employee may be terminated if basic competencies related to the medication use
process are not demonstrated.

9.0 The following resources were used
to prepare the above policy:
Best Practices for Health-System Pharmacy
Position and Practice Standards of ASHP 19981999. Bethesda, MD: American Society of
Health-System Pharmacists, 1998.
Chesapeake General Hospital. Medication System
Analysis Policy and Procedure. Chesapeake, VA:
Chesapeake General Hospital, 1997.
Coe, Charles P. Preparing the Pharmacy for a
Joint Commission Survey. 4th ed. Bethesda,
MD: American Society of Health System
Pharmacists, 1998.
Frederick Memorial Hospital. “Discipline
Process.” FMH Housewide Manual, HR.510.
Frederick, MD: Frederick Memorial
Hospital, 1999.

Frederick Memorial Hospital. “Procedure for
Conducting a ‘Root Cause Analysis’ (RCA).”
FMH Housewide Manual, PI.112. Frederick,
MD: Frederick Memorial Hospital, 1999.
Frederick Memorial Hospital. “Sentinel Events.”
FMH Housewide Manual, PI.111. Frederick,
MD: Frederick Memorial Hospital, 1999.
National Coordinating Council for Medication
Reporting and Prevention. NCC MERP
Taxonomy of Medication Errors. Rockville, MD:
National Coordinating Council for Medication
Reporting and Prevention, 1998. Available at:
http://www.nccmerp.org/taxo0731.pdf
Accessed November 12, 2002.
Newton-Wellesley Hospital. Medication Error
and Adverse Drug Event Policy. Newton, MA:
Newton-Wellesley Hospital, 2000.

www.medpathways.info

1.H.6

2002© American Hospital Association, Health Research & Educational Trust,
and the Institute for Safe Medication Practices

Illustrative example of a no-blame policy for providers participating in the pilot of the CRSPS

Principles of a Fair and Just Culture

Background
It is inevitable that people will make mistakes or experience misunderstandings in any work
environment. When events occur that cause harm or have the potential to cause harm to patients or
staff members, or that place the XXXXXXX at legal, financial or ethical risk, a choice exists: to
learn or to blame. The XXXXXXX is committed to creating a work environment that emphasizes
learning rather than blame.
The XXXXXXX recognizes the complexity and interdependence of the work environment in all
aspects of its operations, including patient care, clinical operations, research, support services and
administration. The intent is to promote an atmosphere where any employee can openly discuss
errors of commission or omission, process improvements, and/or systems corrections without the
fear of reprisal.
It is well documented that most errors, whether or not they cause harm, are due to breakdowns in
organizational systems; however, when an error takes place, individual culprits are often sought.
Blaming individuals creates a culture of fear and defensiveness that diminishes both learning and the
capacity to constantly improve systems.
Most errors take place within systems that themselves contribute to the error. In spite of this, it is
difficult to create an institutional culture that integrates the understanding that systems failures are
the root cause of most errors. Learning from errors often points to beneficial changes in systems and
management processes as well as in individual behavior.
In the context of promoting a fair and just culture, what does it mean? A fair and just culture means
giving constructive feedback and critical analysis in skillful ways, doing assessments that are based
on facts, and having respect for the complexity of the situation. It also means providing fair-minded
treatment, having productive conversations, and creating effective structures that help people reveal
their errors and help the organization learn from them. A fair and just culture does not mean nonaccountable, nor does it mean an avoidance of critique or assessment of competence. Rather, when
incompetence or sub-standard performance is revealed after careful collection of facts, and/or there
is reckless or willful violation of policies or negligent behavior, or behavior that intimidates others
and creates a hostile work environment, will not be tolerated. Corrective or disciplinary action may
be appropriate, following the process outlined in the Professional Behavior and Reporting
Procedures Policy.
Applying these principles creates an opportunity to enact the core values of the XXXXXXX. In
order to have the greatest impact and achieve the highest level of excellence, staff must be able to
speak up about problems, errors, conflicts and misunderstandings in an environment where it is the
shared goal to identify and discuss problems with curiosity and respect. To achieve excellence,
unwanted or unexpected outcomes and inefficiencies of practice must be used as the basis for a
learning process. Respect must be shown to all people at every level of the organization.

1

Illustrative example of a no-blame policy for providers participating in the pilot of the CRSPS

Principles of a Fair and Just Culture
1. The XXXXXXX strives to create a learning environment and a workplace that supports the core values
of impact, excellence, respect/compassion and discovery in every aspect of work at the XXXXXXX.
2. The XXXXXXX supports the efforts of every individual to deliver the best work possible. When errors
are made and/or misunderstandings occur, the XXXXXXX strives to establish accountability in the
context of the system in which they occurred.
We commit to creating an institutional work environment that is least likely to cause or
support error.
We are proactive about identifying system flaws.
3. The XXXXXXX commits to holding individuals accountable for their own performance in accordance
with their job responsibilities and The XXXXXXX’s core values. However, individuals should not carry
the burden for system flaws over which they had no control.
4. The XXXXXXX promotes open interdisciplinary discussion of untoward events (errors, mistakes,
misunderstandings or system failures resulting in harm, potential harm or adverse outcome) by all who
work, visit or are cared for at the XXXXXXX.
We commit to developing and maintaining easily available and simple processes to
discuss untoward events.
We commit to eliciting different points of view to identify sources of untoward events and
to use the information to improve the working and care environment.
We commit to fostering an interdisciplinary teamwork approach to the analysis of
untoward events and to the actions taken to address them.
We believe that individuals are responsible for surfacing untoward events and for
contributing to the elimination of system flaws.
We commit to analyzing episodes of institutional or patient harm or potential harm in an
unbiased fashion to best determine the contributions of system and individual factors.
We seek solutions that promote simplification and standardization wherever possible.
5. The XXXXXXX acts to improve all areas of the workplace by implementing changes based on our
analysis of problems and potential or actual harm.
We know that actions designed to address the root causes of untoward events will
improve the effectiveness of our work environment and the safety of care. We commit to
identifying and assigning responsibility for implementing those actions to specific
individuals or groups.
We commit to developing timely and effective follow-up and an effective organizational
culture through education and systems for ensuring on-going competency.
6. The XXXXXXX commits to a culture of inclusion and education.
We commit to fostering a culture that is concerned with safety in research, clinical care
and administration through continuous education, proactive interventions and
safety-based leadership.
We believe that patient input is indispensable to the delivery of safe care and we commit
to promoting patient and family participation.
7. The XXXXXXX will assess our success in promoting a learning environment by evaluating our
willingness to communicate openly and by the improvements we achieve.
We commit to monitoring actions and attitudes for their effectiveness in supporting a
culture of safety and modifying actions as needed.

[Principles adapted from Allan Frankel, M.D. and the Patient Safety Leaders at Partners Healthcare System]

2


File Typeapplication/pdf
File Modified2013-05-17
File Created2002-12-02

© 2024 OMB.report | Privacy Policy